We are live on !
Find out more
Andreas Halvorsen Viking Global Investors
AUM
$35.1B
Turnover
49.55%
1-Year Est. Return
21.36%
Andreas Halvorsen is the founder of Viking Global Investors, another prominent firm with roots in Julian Robertson’s Tiger Management. Viking is known for fundamental long/short equity investing and a large, research-intensive platform. Its public filings are widely monitored for institutional-quality growth and cyclical equity ideas.
This Fund
S&P 500
This Quarter Est. Return
+5.42%
1 Year Est. Return
+21.36%
3 Year Est. Return
+97.07%
5 Year Est. Return
+98.11%
10 Year Est. Return
+504%
AUM
$23.5B
AUM Growth
+$825M
(+3.6%)
Cap. Flow
+$352M
Cap. Flow % of AUM
Cap. Flow %
1.49%
Top 10 Holdings %
Top 10 Hldgs %
54.93%
Holding
76
New
13
Increased
23
Reduced
16
Closed
21
Avg Time Held
0.7
years
Top 10 Avg Time Held
0.4
years
Top 20 Avg Time Held
0.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$785M |
| 2 |
T-Mobile US
TMUS
|
+$463M |
| 3 |
Mastercard
MA
|
+$428M |
| 4 |
Anadarko Petroleum
APC
|
+$352M |
| 5 |
Microsoft
MSFT
|
+$293M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$678M |
| 2 |
Elevance Health
ELV
|
+$674M |
| 3 |
AET
Aetna Inc
AET
|
+$333M |
| 4 |
Teva Pharmaceutical Industries Limited
TEVA
|
+$279M |
| 5 |
TransDigm Group
TDG
|
+$243M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 23.31% |
| 2 | Healthcare | 21.56% |
| 3 | Consumer Discretionary | 15.15% |
| 4 | Energy | 14.21% |
| 5 | Technology | 8.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Amazon
AMZN
$2.8T
| $2.35B | 9.97% |
65,579,680
-3,170,180
| -5% | -$107M |
2015 Q2
4 quarters
|
|
2
Meta Platforms (Facebook)
META
$1.56T
| $2.3B | 9.78% |
20,144,959
+11,706
| +0.1% | +$1.35M |
2016 Q1
1 quarter
|
|
3
Broadcom
AVGO
$1.4T
| $1.59B | 6.75% |
102,197,110
+3,869,630
| +4% | +$58.9M |
2015 Q2
4 quarters
|
|
|
4
Teva Pharmaceutical Industries Limited
TEVA
$49.7B
| $1.39B | 5.92% |
27,736,655
-5,234,967
| -16% | -$279M |
2015 Q3
3 quarters
|
|
5
Alphabet (Google) Class A
GOOGL
$3.5T
| $1.26B | 5.36% |
35,898,540
-5,111,200
| -12% | -$188M |
2015 Q4
2 quarters
|
|
6
Air Products & Chemicals
APD
$67.9B
| $986M | 4.19% |
7,506,899
+39,167
| +0.5% | +$5.22M |
2014 Q3
7 quarters
|
|
7
DELISTED
Coterra Energy
CTRA
| $909M | 3.86% |
35,324,625
-1,078,068
| -3% | -$25.9M |
2015 Q4
2 quarters
|
|
|
8
Biogen
BIIB
$36.7B
| $776M | 3.3% |
3,210,507
+2,979,560
| +1,290% | +$785M |
2015 Q4
2 quarters
|
|
9
Eli Lilly
LLY
$1.21T
| $738M | 3.14% |
9,377,395
-2,386,383
| -20% | -$180M |
2016 Q1
1 quarter
|
|
10
Ovintiv
OVV
$16.3B
| $628M | 2.67% |
16,116,600
| – | – |
2015 Q4
2 quarters
|
|
|
11
T-Mobile US
TMUS
$172B
| $604M | 2.57% |
13,966,540
+11,285,490
| +421% | +$463M |
2016 Q1
1 quarter
|
|
12
Alphabet (Google) Class C
GOOG
$3.49T
| $582M | 2.47% |
16,825,100
-4,302,580
| -20% | -$155M |
2014 Q3
7 quarters
|
|
13
Netflix
NFLX
$260B
| $575M | 2.44% |
62,885,710
-17,711,110
| -22% | -$170M |
2015 Q3
3 quarters
|
|
|
14
Mastercard
MA
$569B
| $566M | 2.41% |
6,432,259
+4,479,636
| +229% | +$428M |
2013 Q2
12 quarters
|
|
15
Newell Brands
NWL
$2.33B
| $483M | 2.05% |
9,936,480
+5,205,834
| +110% | +$243M |
2016 Q1
1 quarter
|
|
16
JD.com
JD
$39.3B
| $478M | 2.03% |
22,494,760
+7,413,825
| +49% | +$179M |
2016 Q1
1 quarter
|
|
17
DELISTED
Southwestern Energy Company
SWN
| $474M | 2.01% |
37,664,133
| – | – |
2015 Q4
2 quarters
|
|
|
AGN
18
DELISTED
Allergan plc
AGN
| $448M | 1.9% |
1,939,703
-2,942,254
| -60% | -$678M |
2013 Q2
12 quarters
|
|
|
19
DELISTED
Anadarko Petroleum
APC
| $416M | 1.77% |
7,802,981
+6,949,514
| +814% | +$352M |
2015 Q4
2 quarters
|
|
20
Range Resources
RRC
$11.4B
| $403M | 1.71% |
9,333,976
+471,306
| +5% | +$19.3M |
2015 Q4
2 quarters
|
|
21
DaVita
DVA
$12B
| $357M | 1.51% |
4,611,729
+2,867,210
| +164% | +$217M |
2016 Q1
1 quarter
|
|
22
Alibaba
BABA
$272B
| $321M | 1.36% |
4,030,758
+2,635,329
| +189% | +$206M |
2014 Q3
7 quarters
|
|
|
CPN
23
DELISTED
Calpine Corporation
CPN
| $300M | 1.28% |
20,366,388
+9,873,137
| +94% | +$146M |
2015 Q4
2 quarters
|
|
24
Intercontinental Exchange
ICE
$96.3B
| $290M | 1.23% |
+5,667,510
| New | +$286M |
2016 Q2
0 quarters
|
|
25
DELISTED
Walgreens Boots Alliance
WBA
| $289M | 1.23% |
3,469,712
-2,809,472
| -45% | -$227M |
2013 Q4
10 quarters
|
|
Similar funds
Andreas Halvorsen's Q2 2016 Portfolio in Review
As of Q2 2016, Andreas Halvorsen held 76 positions worth $23.5B, up 3.6% from $22.7B the previous quarter. Its ten largest holdings account for 55% of the portfolio.
Andreas Halvorsen's Q2 2016 filing shows 13 new, 23 increased, 16 reduced and 21 closed positions. Its largest new stake was Microsoft: 5,633,782 shares worth $288M. The largest sale was Allergan plc, an estimated $678M.
By sector, the portfolio is most concentrated in Communication Services at 23% of assets, down from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Andreas Halvorsen's largest Q2 2016 buy was Microsoft: 5,633,782 shares worth $288M.
- Andreas Halvorsen added most to Biogen in Q2 2016, an estimated $785M increase.
- Andreas Halvorsen's biggest Q2 2016 reduction was Allergan plc, cutting an estimated $678M.
- Andreas Halvorsen fully exited Elevance Health in Q2 2016, selling an estimated $674M.
- Andreas Halvorsen's ten largest holdings make up 55% of its $23.5B portfolio in Q2 2016.
- Andreas Halvorsen opened 13 new positions and closed 21 in Q2 2016.
- Andreas Halvorsen's portfolio value rose 3.6% quarter-over-quarter to $23.5B.
Based on Viking Global Investors's 13F filing for Q2 2016, filed 15 Aug 2016.